Lung cancer

January 5, 2023

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021

Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread

This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
September 20, 2021

The language of (lung) cancer

A new language guide encourages respect, eliminates blame, and promotes health equity
September 20, 2021

Trial Results: Recent ECOG-ACRIN research

Summaries of recently reported ECOG-ACRIN research results